Keyphrases
Clinical Trials
100%
Multiple Sclerosis
100%
Comorbidity
100%
Trial Population
100%
Hypertension
23%
Confidence Interval
15%
High Prevalence
15%
Anxiety-depression
15%
Phase III Clinical Trial
15%
Young Female
15%
Older Individuals
15%
Female Participants
15%
Disability Status
15%
Pooled Prevalence
15%
Diabetes
7%
Young Males
7%
Chronic Lung Disease
7%
Relapsing-remitting multiple Sclerosis
7%
Meta-analysis
7%
Disease Activity
7%
Old Age
7%
Medical History
7%
Aging Level
7%
MS-MS
7%
Prevalence Ratio
7%
Advisory Committee
7%
Limited Information
7%
Depression Prevalence
7%
Study within a Trial
7%
Migraine
7%
Underrepresentation
7%
2-stage
7%
Progressive multiple Sclerosis
7%
Trial Participants
7%
History Data
7%
Maelstrom
7%
Relapsing-remitting MS
7%
I2 Statistic
7%
Progressive MS
7%
Clinical Trial Participation
7%
Anxiety Prevalence
7%
Chronic Comorbidity
7%
Multiple Sclerosis Disease-modifying Therapies
7%
Comorbidity Prevalence
7%
Retrospective Harmonization
7%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Multiple Sclerosis
100%
Prevalence
100%
Comorbidity
100%
Hyperlipidemia
20%
Disease
6%
Disease Activity
6%
Chronic Lung Disease
6%
Medical History
6%
Migraine
6%
Biochemistry, Genetics and Molecular Biology
Clinical Trial
100%
Prevalence
100%
Comorbidity
100%
Hyperlipidemia
20%
Neuroscience
Multiple Sclerosis Clinical Trial
100%
Comorbidity
100%
Multiple Sclerosis
46%
Meta-Analysis
6%
Migraine
6%
Mathematics
Confidence Interval
100%
Statistics
50%
Meta-Analysis
50%